N-Hydroxy-4-(2-trifluoromethyl-phenyl)-pyridine-2-carboxamidine, 95.0%, 1g

2-Isopropyl-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole, 98%, 250mg

N-(2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propane-1-sulfonamide, 95%, 100mg

POTASSIUM TRIFLUORO(2-HYDROXYPHENYL)BORATE, 97.0%, 5g

2-Ethylhexanoic acid, >=99%, for synthesis, 1 L, glass packaging

4,6-Dimethoxysalicylaldehyde>98.0%(GC)(T)5g

Separating funnel With PTFE plugs, 2000 ml, 1 Piece

8-Carboxylic-3H-1,4-Benzodiazepin-2,5-(1H,4H)-dione, 97.0%, 1g

3-(3-Bromo-4-fluorophenyl)propanoic acid, 97.0%, 1g

5-BROMO-7-METHOXY-1H-INDOLE, 95.0%, 1g

5-(Benzyloxy)-2-hydroxybenzaldehyde, 95.0%, 10g

2-(4-(2-Fluoro-5-(3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl)phenyl)-1H-pyrazol-1-yl)ethan-1-ol, 98%, 50mg

7-HYDROXY-4H-CHROMEN-4-ONE, 95.0%, 5g